Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 48% by 2022.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Historically, the company has been releasing figures that are above expectations.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For several months, analysts have been revising their EPS estimates roughly upwards.
The tendency within the weekly time frame is positive above the technical support level at 36.4 USD
Weaknesses
The company sustains low margins.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The company's "enterprise value to sales" ratio is among the highest in the world.
For the past seven days, analysts have been lowering their EPS expectations for the company.
For the past year, analysts have significantly revised downwards their profit estimates.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
